Market Place
Sourcing Support
Vyant Bio Provides Update on Winddown Activities
26 Dec 2023 //
GLOBENEWSWIRE
Vyant Bio Provides Update on Winddown Activities
10 Nov 2023 //
GLOBENEWSWIRE
Vyant Bio Announces Stockholder Approval of Plan of Dissolution
01 Nov 2023 //
GLOBENEWSWIRE
Vyant Bio Announces Completion of StemoniX Asset Sale
24 Oct 2023 //
GLOBENEWSWIRE
Vyant Bio Announces Stockholder Approval of Proposed Asset Sale
19 Oct 2023 //
GLOBENEWSWIRE
Vyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets
11 Oct 2023 //
GLOBENEWSWIRE
Vyant Bio Announces Adjournment of Special Meeting of Stockholders
28 Sep 2023 //
GLOBENEWSWIRE
Vyant Bio Announces Adjournment of Special Meeting of Stockholders
20 Sep 2023 //
GLOBENEWSWIRE
AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio`s StemoniX Assets
17 Jul 2023 //
PR NEWSWIRE
Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15
12 May 2023 //
GLOBENEWSWIRE
Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting & SEC
04 May 2023 //
GLOBENEWSWIRE
Vyant Bio Announces Voluntary Nasdaq Delisting and SEC Deregistration
24 Apr 2023 //
GLOBENEWSWIRE
Vyant Bio Commences a Cash Preservation Plan Including a Reduction in Force
03 Feb 2023 //
GLOBENEWSWIRE
Neurodegenerative biotech Vyant warns of potential wind-down
03 Feb 2023 //
ENDPTS
Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives
04 Jan 2023 //
GLOBENEWSWIRE
Vyant Bio Presents Key Takeaways from Platform & Poster at Neuroscience 2022
16 Nov 2022 //
GLOBENEWSWIRE
Vyant Bio Reports Third Quarter 2022 Results
15 Nov 2022 //
GLOBENEWSWIRE
Vyant Bio Presents Key Takeaways from Platform and Poster at the 2022 CDKL5
10 Nov 2022 //
GLOBENEWSWIRE
Vyant Bio Teams Up with the International Rett Syndrome Foundation
07 Nov 2022 //
GLOBENEWSWIRE
Reaction Biology to acquire Vyant Bio subsidiary’s operations in US
04 Nov 2022 //
PHARMACEUTICAL-TECHNOLOGY
Reaction Biology & Vyant Bio Announce Closing of Definitive Agreement
03 Nov 2022 //
BIOSPACE
Vyant Bio Announces Participation at the 2022 CDKL5 Forum
27 Oct 2022 //
GLOBENEWSWIRE
Vyant to Present at the LD Micro Main Event XV on Wednesday, October 26, 2022
24 Oct 2022 //
GLOBENEWSWIRE
Vyant Bio to Deliver a Live Presentation at the Skyline Signature Series™
01 Sep 2022 //
GLOBENEWSWIRE
Vyant Bio Reports Second Quarter and First Half 2022 Results
22 Aug 2022 //
GLOBENEWSWIRE
Vyant Bio Announces Rescheduled Investor Conference Call for Q1 and Q2 of 2022
19 Aug 2022 //
GLOBENEWSWIRE
Vyant Bio Postpones Second Quarter Investor Conference Call and Webcast
15 Aug 2022 //
GLOBENEWSWIRE
Vyant Bio Announces Investor Conference Call and Webcast for the 2Q
11 Aug 2022 //
GLOBENEWSWIRE
Vyant Bio Retains Skyline Corporate Communications Group, LLC
01 Jun 2022 //
GLOBENEWSWIRE
Vyant Bio Reports First Quarter 2022 Results
16 May 2022 //
GLOBENEWSWIRE
Vyant Bio Announces Investor Conference Call and Webcast for Q1 2022
10 May 2022 //
GLOBENEWSWIRE
Vyant Bio Announces Participation in BioNJ`s 12th BioPartnering Conference
05 May 2022 //
GLOBENEWSWIRE
